Research
Interview Synopsis

Teladoc & the telehealth market in the US

  • Multi-asset Class
  • Healthcare
  • North America

Third Bridge Forum’s recent Teladoc Interview provided clients with invaluable coverage on the healthcare industry, specifically the telehealth market and its place in the US. Our moderator spoke to a former C-level executive at MDLive Inc, who offered opinions on Teladoc and other telehealth providers. For equity and private equity investors looking for updates on the medical sector, who are interested in telehealth investment opportunities, this Interview is particularly pertinent.

Click on the hyperlink below to access the full Forum transcript.

Teladoc: Digital Healthcare Trends and Telehealth in the US

Having explained that the use of telehealth was more underwhelming than expected, the former C-level executive suggested why this was the case. A potential reason given for this included the types of products on offer, with the specialist calling for further innovation and specialisation from companies.

While discussing telehealth’s utilisation rates for older people, the specialist told clients that this will only continue improving when baby boomers begin to use Medicare Advantage insurance plans. The specialist continued by outlining the Medicare Advantage pricing for telehealth services and how the Medicare Advantage market is set to grow with the next generation.

The former C-level executive continued by defining which areas of the health market would be opportune to enter for digital clinics, especially considering the market’s relative maturity. Given the high number of partnerships, acquisitions and mergers within the industry, the specialist explained the Teladoc-UnitedHealthcare relationship and how he thought this would progress. He also discussed Amazon and whether it could be a potential disruptor within the market.

To access all the human insights from Third Bridge’s Teladoc & the Telehealth Market interview, click below to view the full transcript.

Related Transcripts

The information used in compiling this document has been obtained by Third Bridge from experts participating in Forum Interviews. Third Bridge does not warrant the accuracy of the information and has not independently verified it. It should not be regarded as a trade recommendation or form the basis of any investment decision.

For any enquiries, please contact sales@thirdbridge.com